A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immatics N.V. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 7,433,707 shares of IMTX stock, worth $69.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,433,707
Previous 6,304,672 17.91%
Holding current value
$69.5 Million
Previous $66.3 Million 30.36%
% of portfolio
0.05%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$9.78 - $13.49 $11 Million - $15.2 Million
1,129,035 Added 17.91%
7,433,707 $86.4 Million
Q1 2024

May 15, 2024

BUY
$10.23 - $12.94 $35.6 Million - $45 Million
3,480,503 Added 123.24%
6,304,672 $66.3 Million
Q4 2023

Feb 14, 2024

BUY
$7.36 - $10.89 $4.37 Million - $6.46 Million
593,333 Added 26.6%
2,824,169 $29.7 Million
Q3 2023

Nov 14, 2023

BUY
$11.01 - $12.62 $195,108 - $223,639
17,721 Added 0.8%
2,230,836 $25.8 Million
Q2 2023

Aug 14, 2023

BUY
$5.92 - $12.72 $13.1 Million - $28.2 Million
2,213,115 New
2,213,115 $25.5 Million

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $713M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.